nkhani
Nkhani

Daiichi Sankyo Akulengeza Zotsatira za Mayesero a Booster Katemera

Tokyo, Japan - (Novembala 15, 2022) - Daiichi Sankyo (TSE: 4568) lero alengeza kuti pakuyesa kuyesa mphamvu ndi chitetezo cha katemera wa booster ndi DS-5670, katemera wa mRNA motsutsana ndi matenda opatsirana a coronavirus (COVID -19) ikupangidwa ndi Daiichi Sankyo (pambuyo pake, kuyesa kwa katemera wa booster), mapeto oyambirira adakwaniritsidwa.Kuyesa kwa katemera wa booster kunaphatikizapo pafupifupi 5,000 achikulire athanzi ku Japan ndi anthu okalamba omwe adamaliza mndandanda wa katemera wa mRNA wovomerezeka ku Japan miyezi isanu ndi umodzi asanalembetse.Mu Januware 2022, kuyesako kudayambika ngati gawo la 1/2/3 kuyesa kuwunika mphamvu ndi chitetezo cha katemera wa booster ndi DS-5670 pogwiritsa ntchito katemera wa mRNA wovomerezedwa ku Japan ngati wowongolera.GMFR ya neutralizing antibody titer motsutsana ndi SARS-CoV-2 (kusemphana koyambirira) m'magazi patadutsa milungu inayi katemera wa booster, mapeto oyambirira a mayeso a katemera wa booster, adawonetsa zambiri komanso kusakhala pansi kwa DS-5670 ku katemera wa mRNA. original strain) zovomerezeka ku Japan, kukwaniritsa cholinga chomwe chinafunidwa.Palibe nkhawa zachitetezo zomwe zidadziwika.Tsatanetsatane wa zoyeserera za katemera wa chilimbikitso zidzakambidwa pamisonkhano yamaphunziro ndi m'mapepala ofufuza.Kutengera zotsatira za mayesowo, Daiichi Sankyo apitiliza kukonzekera kugwiritsa ntchito katemera wa mRNA mu Januware 2023. Kuphatikiza apo, Daiichi Sankyo akukonzekera kuyesa katemera wa bivalent wa mtundu woyambirira komanso mitundu ya Omicron motsutsana ndi ma coronaviruses atsopano, zomwe zimapitilira kusintha.Daiichi Sankyo ayesetsa kulimbikitsa njira yopangira katemera wa mRNA kuti atsimikizire kupezeka kokhazikika munthawi wamba komanso kupereka katemera mwachangu pakabuka matenda omwe akungobwera kumene.

Za DS-5670 DS-5670 ndi katemera wa mRNA wolimbana ndi COVID-19 pogwiritsa ntchito ukadaulo waukadaulo wa nucleic acid wopezeka ndi Daiichi Sankyo, wopangidwa kuti apange ma antibodies motsutsana ndi receptor binding domain (RBD) ya spike protein ya novel coronavirus, motero. akuyembekezeka kukhala ndi chitetezo choyenera ku COVID-19 ndi 2 chitetezo.Kuphatikiza apo, Daiichi Sankyo akufuna katemera wa mRNA yemwe amatha kugawidwa mufiriji kutentha (2-8°C)

img1

Nthawi yotumiza: Dec-17-2022